Filter
128
Filtered Results: 128
Text search:
Novartis
Featured
Recommendations
12
New Publications
41
Language
Document type
No document type
83
Studies & Reports
24
Guidelines
13
Strategic & Response Plan
4
Fact sheets
2
Manuals
1
Situation Updates
1
Countries / Regions
Tanzania
6
Global
4
India
4
South Africa
3
Russia
3
Indonesia
3
Ukraine
2
Ghana
2
Nigeria
2
Philippines
2
Cambodia
2
Latin America and the Carribbean
2
Germany
2
Western and Central Europe
2
Brazil
2
Nepal
1
Kenya
1
Sierra Leone
1
Chile
1
Malawi
1
Mozambique
1
Africa
1
Asia
1
Venezuela
1
Bangladesh
1
Namibia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Policies
10
Policies & Guidelines HIV & TB
6
Guidelines
6
Drugs & Medical Equipment
5
Pharmacy & Technologies
5
Studies & Reports
4
Leprosy
4
NTDs & Others
4
COVID-19
3
Health System Strengthening
3
Infection Control & Prevention (IPC)
2
Disabilities
2
Non-communicable Diseases
2
Diabetes
1
Community Health
1
Virology
1
Pediatrics
1
Vaccine-preventable Diseases
1
Chagas
1
Clinical Guidelines
1
Women & Child Health
1
Community Health
1
Humanitarian Crisis
1
Leprosy
1
Other
1
WASH
1
Surgery & Anaesthesia
1
Maternal Health
1
Primary Health Care
1
Laboratory Quality Assurance
1
HIV & STI
1
Age & Elderly
1
Disease Prevention & Control
1
TB
1
Toolboxes
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
14
Children/Adolescents Mental Disorders
14
Policies & Strategies
11
Prevention & Control
4
Essential Medicines
4
Prices and Patents
4
Neurological Disorders
4
National Policies
3
Attention deficit hyperactivity disorder (ADHD)
3
Country Guidelines
3
General
3
Country specific documents
3
Studies & Reports
3
Overview, Studies & Reports
3
Diagnosis
3
Drug resistant TB
3
Alzheimer's Disease & Dementia
3
Treatment & Clinical Management
3
Public Health
2
Long COVID/ Post-COVID Syndrome
2
One Health
2
Zoonoses
2
General
2
Human Rights & the Right to Health
2
Research & Access
2
Vision Loss & Blindness
2
Clinical Guidelines
1
Policies & Strategies
1
Assessment & Studies
1
General Reports
1
Agriculture & Veterinary
1
Clinical Guidelines
1
IPC
1
Background PTSD in children
1
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Adults
1
Diagnosis & Treatment PTSD in Children
1
Introduction to Global Health
1
Schizophrenia
1
Human Rights, Stigma & Discrimination
1
Inclusion
1
General Studies & Reports
1
IEC Materials
1
Latin America
1
Research
1
Mental Health Guidelines
1
Epilepsy
1
General
1
Studies
1
Health Personnel
1
Fair Allocation & Ethical Aspects
1
Research & Pipeline
1
Hygiene
1
Primary Care
1
Community Health Workers CHW
1
Pharmacy
1
Falsified & Substandard
1
Quality Assurance
1
Epilepsy
1
General Guidelines for Rational Use
1
Pharmaceutical Dosage Forms
1
Health Care Systems
1
General
1
Chagas
1
Strategies & Roadmaps
1
Studies & Reports
1
Studies & Reports
1
Foodborn trematodiasis
1
Global Overview
1
General
1
others
1
Bipolar Affective Disorders
1
Assessment
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Stigma
1
Antiretroviral Treatment ART
1
Guidelines CBR
1
Eastern Europe & Central Asia
1
Meningitis & Encephalitis
1
Neurological disorders, Others
1
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Europe PMC Funders Group
Author Manuscript
Arch Dis Child. Author manuscript; available in PMC 2013 November 01.
Published in final edited form as:
Arch Dis Child. 2013 May ; 98(5): 323–327. doi:10.1136/archdischild-2012-302079.
Trastornos externalizantes
Capítulo D.1.1
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Carlos Gómez
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
National Action Plan: Programmatic Management of Drug Resistance Tuberculosis, Tuberculosis Control Indonesia
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
GUIDELINES ON LEPROSY CONTROL IN SOUTH AFRICA | 2011
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
